BioSpace News Archive

Lamassu Pharma LLC, a privately held Biotech announced today it has received $1.5 million in Small Business Innovation Research (SBIR) grant funding from the National Institutes of Health (NIH). This will be used for further development of its lead therapeutic compound, RABI-767, a novel small molecule lipase inhibitor licensed from t

SOTIO , a clinical stage immuno-oncology company owned by PPF Group, today announced that the first patient has been dosed in Part B of the ongoing Phase 1/1b study of IL-15 superagonist, SO-C101, for the treatment of patients with advanced/metastatic solid tumors. Part B will examine SO-C101 in combination with PD-1 inhibitor pembrolizumab. The trial is conducted in partnership with Cytune Pharma. Early results from the ongoin

10x Genomics  (Nasdaq: TXG) strengthened the research toolkit of scientists around the globe today with the launch of its Chromium Single Cell Immune Profiling v2 product. The new product extends the capabilities of the original version, supporting fundamental breakthroughs in immunology, oncology, autoimmunity, inflammation, transplant biology, and infectious diseases. It also significantly builds on the existing product that is bein

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, today announced that Brian H. Santich, PhD, from Memorial Sloan Kettering (“MSK”) will present an update on the Company’s SADA technology platform at the Society of Nuclear Medicine and Molecular Imaging (“SNMMI”)

ValueHealth, a nationally recognized technology-enabled healthcare services company with a surgical digital platform, is pleased to announce the appointment of Ron Baker, FACHE, CMPE as President of NueHealth, ValueHealth’s multi-specialty and single-specialty service offering.

Partnership promotes image exchange with a true zero footprint; improves interoperability between providers

Waystar, a leading provider of revenue cycle technology for the healthcare industry, today announced the appointment of Ursula Burns, retired Chair and CEO of VEON Ltd. and Xerox Corporation, to its board of directors.

Celdara Medical (“Celdara”) today announced the launch of its Pandemic Security Initiative, harnessing the resources needed to prepare the nation for future infectious disease pandemics.

General Motors has received N95 certification for the filtering facepiece respirators made at the company’s Warren, Michigan facility.

USANA ® , a leader in cellular nutrition, is honored to receive another seal of approval from third-party tester ConsumerLab.com . This time for its flagship supplement, USANA CellSentials .